CLGN CollPlant Biotechnologies Ltd.
$3.50▼ -1.13%
Healthcare
Other
After hours
$3.50▲ +0.00%
Sep 11, 7:30 PM ET
Volume 126.9K
Avg Volume (10D) 2.10M
Key Metrics & Fundamentals
Market Cap
$6.62M
P/E Ratio
–
Div Yield
–%
52W Range
2.64 - 31.80
% vs 50 MA
6.79%
% vs 200 MA
-52.99%
RSI-14
54.4
MACD Histogram
+0.0300
Beta (1Y vs SPY)
1.18
Free Cash Flow
-$3.06M
Gross Rev
$73,000
Gross Profit
-$243,000
EBITDA
-$2.91M
COGS
$316,000
Operating Exp
$2.87M
Operating Income
-$3.12M
EBIT
-$3.12M
Pretax Income
-$3.10M
Net Income
-$3.10M
EPS (Diluted)
-0.23
Price & Volume History
Loading chart…
Recent News

CollPlant to Host LightSolver Investor Webinar on September 17, 2026
PR Newswire · Sep 10, 2026 11:00 AM

COLLPLANT APPOINTS DR. RUTI BEN SHLOMI TO ITS BOARD OF DIRECTORS FOLLOWING CLOSING OF LIGHTSOLVER ACQUISITION
PR Newswire · Sep 4, 2026 11:00 AM

COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR
PR Newswire · Sep 3, 2026 12:00 PM
CollPlant to Implement 1-for-10 Reverse Stock Split
MT Newswires · Sep 1, 2026 8:52 PM

COLLPLANT ANNOUNCES REVERSE SHARE SPLIT
PR Newswire · Sep 1, 2026 8:01 PM
BC-Most Active Stocks
Associated Press · Aug 31, 2026 2:30 PM

COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PHOTONIC COMPUTING MARKETS
PR Newswire · Aug 31, 2026 12:00 PM
CollPlant Biotechnologies Files Prospectus for Resale of 31 Million Shares
MT Newswires · Jul 9, 2026 9:29 PM
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT
PR Newswire · Jun 30, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
Mar 2026
See CLGN's money flow as a full page
Social Sentiment
No Reddit posts found for CLGN.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.